BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15142563)

  • 1. Antibacterial chalcones--bioisosteric replacement of the 4'-hydroxy group.
    Nielsen SF; Boesen T; Larsen M; Schønning K; Kromann H
    Bioorg Med Chem; 2004 Jun; 12(11):3047-54. PubMed ID: 15142563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of antibacterial chalcones.
    Avila HP; Smânia Ede F; Monache FD; Smânia A
    Bioorg Med Chem; 2008 Nov; 16(22):9790-4. PubMed ID: 18951808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids.
    Selvakumar N; Kumar GS; Azhagan AM; Rajulu GG; Sharma S; Kumar MS; Das J; Iqbal J; Trehan S
    Eur J Med Chem; 2007 Apr; 42(4):538-43. PubMed ID: 17150281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic chalcone antibiotics. Design, synthesis, and mechanism of action.
    Nielsen SF; Larsen M; Boesen T; Schønning K; Kromann H
    J Med Chem; 2005 Apr; 48(7):2667-77. PubMed ID: 15801857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents.
    Sivakumar PM; Priya S; Doble M
    Chem Biol Drug Des; 2009 Apr; 73(4):403-15. PubMed ID: 19291103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, physicochemical properties and antimicrobial evaluation of new (E)-chalcones.
    Nowakowska Z; Kedzia B; Schroeder G
    Eur J Med Chem; 2008 Apr; 43(4):707-13. PubMed ID: 17618710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents.
    Sivakumar PM; Ganesan S; Veluchamy P; Doble M
    Chem Biol Drug Des; 2010 Nov; 76(5):407-11. PubMed ID: 20925692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus.
    Liu XL; Xu YJ; Go ML
    Eur J Med Chem; 2008 Aug; 43(8):1681-7. PubMed ID: 18031869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted.
    Batovska D; Parushev S; Stamboliyska B; Tsvetkova I; Ninova M; Najdenski H
    Eur J Med Chem; 2009 May; 44(5):2211-8. PubMed ID: 18584918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid identification of antibacterial agents effective against Staphylococcus aureus using small-molecule macroarrays.
    Bowman MD; O'Neill JC; Stringer JR; Blackwell HE
    Chem Biol; 2007 Apr; 14(4):351-7. PubMed ID: 17462570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid-catalyzed synthesis of oxathiolone fused chalcones. Comparison of their activity toward various microorganisms and human cancer cells line.
    Konieczny MT; Konieczny W; Sabisz M; Skladanowski A; Wakieć R; Augustynowicz-Kopeć E; Zwolska Z
    Eur J Med Chem; 2007 May; 42(5):729-33. PubMed ID: 17300856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
    Tomar V; Bhattacharjee G; Kamaluddin ; Kumar A
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5321-4. PubMed ID: 17719779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microwave-assisted preparation of azachalcones and their N-alkyl derivatives with antimicrobial activities.
    Usta A; Öztürk E; Beriş FŞ
    Nat Prod Res; 2014; 28(7):483-7. PubMed ID: 24571646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of the 4-quinolone-3-carboxylic acid derivatives having a trifluoromethyl group as a novel N-1 substituent.
    Asahina Y; Araya I; Iwase K; Iinuma F; Hosaka M; Ishizaki T
    J Med Chem; 2005 May; 48(9):3443-6. PubMed ID: 15857152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of prenylated benzaldehydes and their use in the synthesis of analogues of licochalcone A.
    Kromann H; Larsen M; Boesen T; Schønning K; Nielsen SF
    Eur J Med Chem; 2004 Nov; 39(11):993-1000. PubMed ID: 15501549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of nocathiacin I analogues.
    Naidu BN; Sorenson ME; Matiskella JD; Li W; Sausker JB; Zhang Y; Connolly TP; Lam KS; Bronson JJ; Pucci MJ; Yang H; Ueda Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3545-9. PubMed ID: 16621551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved small-molecule macroarray platform for the rapid synthesis and discovery of antibacterial chalcones.
    Stringer JR; Bowman MD; Weisblum B; Blackwell HE
    ACS Comb Sci; 2011 Mar; 13(2):175-80. PubMed ID: 21210707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis of natural p-quinol cochinchinenone.
    Barradas S; Hernández-Torres G; Urbano A; Carreño MC
    Org Lett; 2012 Dec; 14(23):5952-5. PubMed ID: 23167295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antimicrobial studies on novel chloro-fluorine containing hydroxy pyrazolines.
    Karthikeyan MS; Holla BS; Kumari NS
    Eur J Med Chem; 2007 Jan; 42(1):30-6. PubMed ID: 17007964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, theoretical, anti-bacterial and molecular docking studies of quinoline based chalcones as a DNA gyrase inhibitor.
    Abdullah MI; Mahmood A; Madni M; Masood S; Kashif M
    Bioorg Chem; 2014 Jun; 54():31-7. PubMed ID: 24747187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.